ALNYLAM PHARMACEUTICALS, INC. reports

Company location: Cambridge, MA
Fiscal year end: 31 December

ALNYLAM PHARMACEUTICALS, INC. has filed 1,657 SEC EDGAR filings since 09 Jul 2002

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 176-200 of 207 matching filings.

Per page

Current page

8-K File 000-50743

FORM 8-K

Filing date: 16 Feb 2012
Reporting date: 15 Feb 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 15 Feb 2012
Reporting date: 15 Feb 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date: 09 Feb 2012
Reporting date: 09 Feb 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 20 Jan 2012
Reporting date: 19 Jan 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 17 Jan 2012
Reporting date: 17 Jan 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 09 Jan 2012
Reporting date: 08 Jan 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 10 Nov 2011
Reporting date: 04 Nov 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date: 01 Nov 2011
Reporting date: 01 Nov 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date: 01 Aug 2011
Reporting date: 01 Aug 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 29 Jun 2011
Reporting date: 28 Jun 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 13 Jun 2011
Reporting date: 09 Jun 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 10 Jun 2011
Reporting date: 09 Jun 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 07 Jun 2011
Reporting date: 02 Jun 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date: 02 May 2011
Reporting date: 30 Apr 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 07 Apr 2011
Reporting date: 06 Apr 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 25 Mar 2011
Reporting date: 21 Mar 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 23 Mar 2011
Reporting date: 22 Mar 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 17 Mar 2011
Reporting date: 16 Mar 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743

FORM 8-K

Filing date: 15 Mar 2011
Reporting date: 14 Mar 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50743